Company logo

SNDX - Syndax Pharmaceuticals, Inc.

NASDAQ -> Healthcare -> Biotechnology
Waltham, United States
Type: Equity

SNDX price evolution
SNDX
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $295.61 $94.77 $97.49 $57.63
Short term investments $282.19 $279.27 $308.75 $380.69
Net receivables $1.23 $3.41 $0.53 $1.39
Inventory
Total current assets $580.88 $380.97 $409.08 $441.51
Long term investments $29.83 $15.71 $19.48 $16.56
Property, plant & equipment $1.5 $1.74 $1.98 $0.95
Goodwill & intangible assets
Total noncurrent assets $32 $18.25 $22.26 $18.32
Total investments $312.02 $294.98 $328.23 $397.25
Total assets $612.88 $399.22 $431.34 $459.83
Current liabilities
Accounts payable $17.19 $6.05 $11.47 $8.06
Deferred revenue
Short long term debt $1.05 $1.01 $0.97 $0.46
Total current liabilities $58.1 $39.17 $30.17 $23.72
Long term debt $0.59 $0.86 $1.13 $0.6
Total noncurrent liabilities $0.59 $0.86 $1.13 $0.6
Total debt $1.64 $1.87 $2.1 $1.06
Total liabilities $58.68 $40.04 $31.3 $24.32
Shareholders' equity
Retained earnings -$902.4 -$829.93 -$778.78 -$734.17
Other shareholder equity $0.22 -$0.46 -$0.57 -$0.34
Total shareholder equity $554.2 $359.19 $400.04 $435.5
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $295.61 $74.47 $222.08 $115.36
Short term investments $282.19 $410.04 $217.97 $177.82
Net receivables $1.23 $4.06 $0.43 $0.2
Inventory
Total current assets $580.88 $489.79 $448.4 $298.86
Long term investments $29.83 $5.47
Property, plant & equipment $1.5 $1.06 $1.26 $0.48
Goodwill & intangible assets
Total noncurrent assets $32 $7.45 $1.26 $1.75
Total investments $312.02 $415.51 $217.97 $177.82
Total assets $612.88 $497.24 $449.66 $300.61
Current liabilities
Accounts payable $17.19 $4.35 $5.67 $3.51
Deferred revenue $13.13
Short long term debt $1.05 $0.44 $0.36 $2.6
Total current liabilities $58.1 $29.07 $20.68 $18.87
Long term debt $0.59 $0.01 $20.61 $17.93
Total noncurrent liabilities $0.59 $0.72 $20.61 $29.55
Total debt $1.64 $1.16 $20.97 $20.54
Total liabilities $58.68 $29.79 $41.29 $48.42
Shareholders' equity
Retained earnings -$902.4 -$693.04 -$543.7 -$568.63
Other shareholder equity $0.22 -$0.81 $0.04 -$0
Total shareholder equity $554.2 $467.45 $408.37 $252.19
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $55.13 $39.09 $34.76 $34.05
Selling, general & administrative $22.78 $17.27 $14.91 $11.96
Total operating expenses $77.91 $56.35 $49.68 $46.02
Operating income -$77.91 -$56.35 -$49.68 -$46.02
Income from continuing operations
EBIT -$72.41 -$51.08 -$44.58 -$41.09
Income tax expense
Interest expense $0.06 $0.07 $0.04 $0.04
Net income
Net income -$72.47 -$51.15 -$44.62 -$41.13
Income (for common shares) -$72.47 -$51.15 -$44.62 -$41.13
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $139.71 $1.52
Cost of revenue
Gross Profit $139.71 $1.52
Operating activities
Research & development $163.03 $118.5 $88.25 $50.44
Selling, general & administrative $66.92 $33.26 $25.24 $22.5
Total operating expenses $229.95 $151.76 $113.49 $72.94
Operating income -$229.95 -$151.76 $26.22 -$71.42
Income from continuing operations
EBIT -$209.15 -$146.2 $26.82 -$74.71
Income tax expense
Interest expense $0.21 $3.14 $1.9 $2.36
Net income
Net income -$209.36 -$149.34 $24.93 -$77.06
Income (for common shares) -$209.36 -$149.34 $24.93 -$77.06
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$72.47 -$51.15 -$44.62 -$41.13
Operating activities
Depreciation $0.25 $0.24 $0.15 $0.11
Business acquisitions & disposals
Stock-based compensation $8.33 $8.32 $8.06 $6.24
Total cash flows from operations -$41.35 -$44.65 -$35.37 -$39.23
Investing activities
Capital expenditures
Investments -$16.29 $40.08 $73.91 $19.91
Total cash flows from investing -$16.29 $40.08 $73.91 $19.91
Financing activities
Dividends paid
Sale and purchase of stock $258.48 $1.85 $1.32 $2.47
Net borrowings
Total cash flows from financing $258.48 $1.85 $1.32 $2.47
Effect of exchange rate
Change in cash and equivalents $200.84 -$2.73 $39.86 -$16.84
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$209.36 -$149.34 $24.93 -$77.06
Operating activities
Depreciation $0.75 $0.45 $0.46 $0.52
Business acquisitions & disposals
Stock-based compensation $30.95 $16.02 $13.32 $9.06
Total cash flows from operations -$160.6 -$133.68 $29.13 -$71.26
Investing activities
Capital expenditures $0.23 -$0.13
Investments $117.61 -$186.41 -$40.74 -$142.53
Total cash flows from investing $117.61 -$186.19 -$40.87 -$142.53
Financing activities
Dividends paid
Sale and purchase of stock $264.13 $193.25 $117.89 $284.69
Net borrowings -$21 $0.58 $19.73
Total cash flows from financing $264.13 $172.25 $118.46 $304.42
Effect of exchange rate
Change in cash and equivalents $221.14 -$147.61 $106.72 $90.63
Fundamentals
Market cap $1.96B
Enterprise value $1.66B
Shares outstanding 84.83M
Revenue $0.00
EBITDA -$208.40M
EBIT -$209.15M
Net Income -$209.36M
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio -9.35
EV/Sales N/A
EV/EBITDA -7.98
EV/EBIT -7.95
P/S ratio N/A
P/B ratio 3.53
Book/Share 6.53
Cash/Share 3.48
EPS -$2.47
ROA -44.00%
ROE -47.88%
Debt/Equity 0.11
Net debt/EBITDA 1.14
Current ratio 10.00
Quick ratio 10.00